Great news....
- no abnormal or negative clinical observations in any
of the in-life parameters
- dosing completed mid-dec
- RESULTS ON TRACK for Q1 2014
- Australian PATENT accepted. Others on the way.
This de-risks us again. IMO we are currently priced based on a moderate chance for 1103 success only. Plenty of other irons in the fire that havn't been priced in.
Expecting a very good run for ANP into Q1 next year especcially with 1103 results due then as well.
atl1102 update, page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $10.98K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 921845 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 284463 | 3 |
View Market Depth
| Last trade - 11.51am 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |